# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000875045-16-000076
Filing Date
2016-12-19
Accepted
2016-12-19 17:19:20
Documents
5
Period of Report
2016-12-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | december1920168-k.htm | 8-K | 36143
2 | EXHIBIT 10.1 | biogenemploymentagreementf.htm | EX-10.1 | 158387
3 | EXHIBIT 99.1 | pressreleasedateddecember1.htm | EX-99.1 | 15423
4 |  | biogenlogo.jpg | GRAPHIC | 17556
5 |  | biogenlogostandarda07.jpg | GRAPHIC | 756402
| Complete submission text file | 0000875045-16-000076.txt |  | 1256798

Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 162059691
SIC: 2836 Biological Products, (No Diagnostic Substances)